Show simple item record

dc.contributor.authorChauvin, M
dc.contributor.authorBorys, D
dc.contributor.authorBotta, F
dc.contributor.authorBzowski, P
dc.contributor.authorDabin, J
dc.contributor.authorDenis-Bacelar, AM
dc.contributor.authorDesbree, A
dc.contributor.authorFalzone, N
dc.contributor.authorLee, BQ
dc.contributor.authorMairiani, A
dc.contributor.authorMalaroda, A
dc.contributor.authorMathieu, G
dc.contributor.authorMcKay, E
dc.contributor.authorMora-Ramirez, E
dc.contributor.authorRobinson, Andrew P
dc.contributor.authorSarrut, D
dc.contributor.authorStruelens, L
dc.contributor.authorVergara Gil, A
dc.contributor.authorBardies, M
dc.date.accessioned2020-04-22T07:25:04Z
dc.date.available2020-04-22T07:25:04Z
dc.date.issued2020en
dc.identifier.citationCohen R, Vernerey D, Bellera C, Meurisse A, Henriques J, Paoletti X, et al. Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. Eur J Cancer. 2020;130:63-71.en
dc.identifier.pmid32169912en
dc.identifier.doi10.2967/jnumed.119.240366en
dc.identifier.urihttp://hdl.handle.net/10541/622885
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.2967/jnumed.119.240366en
dc.titleOpenDose: open access resources for nuclear medicine dosimetryen
dc.typeArticleen
dc.contributor.departmentCentre de Recherches en Cancerologie de Toulouse (CRCT) UMR 1037, Inserm, Universite Toulouse III Paul Sabatier, Toulouse, France.en
dc.identifier.journalJournal of Nuclear Medicineen
dc.description.noteen]
refterms.dateFOA2020-04-22T08:50:24Z


Files in this item

Thumbnail
Name:
32169912.pdf
Size:
1.749Mb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record